Drug Design and Drug Development

Drug design, as often as possible insinuated as an adjusted prescription blueprint or basically rational arrangement, is the inventive methodology of finding new pharmaceuticals in perspective of the data of a natural target. The prescription is most typically a characteristic little particle that starts or curbs the limit of a biomolecule, for instance, a protein, which accordingly achieves a remedial favorable position to the patient.

  • Molecular Modeling
  • Kinase Inhibitor Chemistry
  • Blood-Brain Penetrant Inhibitors
  • GPCR-Targeted Drug Design
  • Protein-Protein Interactions
  • Inflammation Inhibitors
  • Small Molecules for Cancer Immunotherapy
  • Biophysical Approaches for Drug Discovery
  • Macrocyclic & Constrained Peptides
  • Fragment-Based Drug Discovery
  • Biomarkers and Clinical Research

Related Conference of Drug Design and Drug Development

January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France

Drug Design and Drug Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in